After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result ...
New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...
Verywell Health on MSN
What Causes Huntington’s Disease?
Huntington's disease is caused by an inherited genetic change that causes production of an altered protein. This leads to nerve damage in areas of the brain that control movement and thinking.
Under the terms of a prior agreement with AbelZeta, AstraZeneca owns the development, manufacturing and commercialization ...
The new recommendation advises people to consume 1.2 grams to 1.6 grams of protein per kilogram of body weight — up to double ...
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...
Regene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback